title: Prevention of experimental autoimmune uveoretinitis by infusions of human therapeutic intravenous immunoglobulins in rats.
authors.affiliation: INSERM U28, Hopital Broussais, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Saoudi
authors.forename: V
authors.initials: V
authors.lastname: Hurez
authors.forename: Y
authors.initials: Y
authors.lastname: De Kozak
authors.forename: J
authors.initials: J
authors.lastname: Kuhn
authors.forename: S V
authors.initials: SV
authors.lastname: Kaveri
authors.forename: M D
authors.initials: MD
authors.lastname: Kazatchkine
authors.forename: P
authors.initials: P
authors.lastname: Druet
authors.forename: B
authors.initials: B
authors.lastname: Bellon
mesh_terms: D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000494:pharmacology; D019393:Arrestin; D001327:Autoimmune Diseases / Q000209:etiology / Q000517:prevention & control*; D005136:Eye Proteins / Q000008:administration & dosage; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology*; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D012173:Retinitis / Q000209:etiology / Q000517:prevention & control*; D014605:Uveitis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000941:Antigens; D000961:Antilymphocyte Serum; D019393:Arrestin; D005136:Eye Proteins; D016756:Immunoglobulins, Intravenous; D007376:Interleukin-2